Predicting Survival and Response to Treatment in Gastroesophageal Neuroendocrine Tumors: An Analysis of the National Cancer Database

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

Medicine, Oncology, Surgery +12

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

Charles G. Moertel, Larry K. Kvols, Michael J. O’Connell et al. · Cancer · 1991 · 839 citations · Full text

Medicine, Endocrinology, Oncology +16

Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study

Guido Rindi, Ombretta Luinetti, Matteo Cornaggia et al. · Gastroenterology · 1993 · 643 citations

Medicine, Oncology, Pathology +16

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

Emmanuel Mitry, Éric Baudin, Michel Ducreux et al. · British Journal of Cancer · 1999 · 495 citations · Full text

Medicine, Oncology, Pharmacology +12

Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors

Sara Ekeblad, Anders Sundin, Eva Tiensuu Janson et al. · Clinical Cancer Research · 2007 · 476 citations · Full text

Medicine, Oncology, Pharmacology +13